Suchergebnisse - "Motoi, Noriko"

PubPharm (269)

21

Long read sequencing reveals a novel class of structural aberrations in cancers: identification and characterization of cancerous local amplifications

enthalten in: bioRxiv.org | 2022

von Sakamoto, Y. | Xu, L. | Seki, M. | +12

22

NSCLC Subtyping in Conventional Cytology : Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Jain, D. | Nambirajan, A. | Chen, G. | +43

23

Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection

enthalten in: The Journal of thoracic and cardiovascular surgery | 2022

von Muraoka, Y. | Yoshida, Y. | Nakagawa, K. | +8

CommentIn: J Thorac Cardiovasc Surg. 2022 May;163(5):1666-1667. - PMID 34340851

24

Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas

enthalten in: Cancer science | 2022

von Noro, R. | Honda, K. | Nagashima, K. | +17

25

Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma

enthalten in: Oncology letters | 2022

von Noguchi, R. | Yoshimatsu, Y. | Ono, T. | +6

26

Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Shirasawa, M. | Yoshida, T. | Imabayashi, T. | +13

CommentIn: Eur J Cancer. 2022 May;167:149-151. - PMID 35307255

27

"Real" Tumor-Spread Through Air Spaces of Lung Adenocarcinoma Presented Intrapulmonary Metastases Through Bronchiole Air Spaces : A Case Report

enthalten in: JTO clinical and research reports | 2022

von Kaku, S. | Motoi, N. | Watanabe, H. | +3

28

Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations

enthalten in: Molecular cancer therapeutics | 2022

von Jo, H. | Yagishita, S. | Hayashi, Y. | +13

29

Elastin in pulmonary pathology : relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint

enthalten in: Histopathology | 2022

von Thunnissen, E. | Motoi, N. | Minami, Y. | +9

30

Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Jo, H. | Yoshida, T. | Horinouchi, H. | +9